Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

AVANOS MEDICAL, INC. Director's Dealing 2021

Jul 15, 2021

32765_dirs_2021-07-15_22f9d738-d0b2-4a64-8e0d-c47079345e68.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Avanos Medical, Inc. (AVNS)
CIK: 0001606498
Period of Report: 2021-07-12

Reporting Person: James Mojirade (SVP, General Counsel)